Bretylium Tosylate

This is a medication that was once used to help lower blood pressure. Now, it's being studied for other uses, like helping with heart rhythm problems.

Brand names:Bretylol
Medication

What people taking Bretylium Tosylate report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Bretylium Tosylate

What It's For

Bretylium tosylate is an emergency heart-rhythm medicine (an antiarrhythmic) given by injection in the hospital. It is approved to prevent and treat ventricular fibrillation, a chaotic rhythm in the heart's lower chambers that stops the heart from pumping and causes cardiac arrest. It is also approved for other life-threatening ventricular rhythms, such as ventricular tachycardia (a dangerously fast rhythm from the same chambers), when a first-line medicine such as lidocaine has not worked. Bretylium was once sold under the brand name Bretylol. It left the US market in 2011, largely because the raw materials needed to make it were unavailable, and it was dropped from the standard cardiac arrest treatment algorithm in 2000 for the same reason. A generic version returned around 2019, but the US Food and Drug Administration (FDA) drug approval database now lists Bretylol and every bretylium injection product as discontinued. Today it is rarely used, and other antiarrhythmic medicines are the usual choices in emergency care.

How It Works

Bretylium acts on the nerves that release norepinephrine, the adrenaline-like messenger that speeds the heart and tightens blood vessels. Right after a dose it briefly triggers a burst of norepinephrine release, which can raise blood pressure and heart rhythm irritability for a short time. It then blocks further release, producing an effect similar to switching off part of the body's fight-or-flight nerve supply. That later blocking effect is why blood pressure often drops, especially when a person sits up or stands. In the heart muscle itself, bretylium lengthens the recovery period between beats and makes ventricular fibrillation harder to start. Exactly how it stops dangerous rhythms is not fully understood. During ventricular fibrillation it can work within minutes, while other ventricular rhythms usually respond more slowly, over 20 minutes to 2 hours.

Dosage & Administration

Bretylium is given only by medical staff, for short-term use, in an intensive care unit, coronary care unit or similar setting where heart rhythm and blood pressure are monitored continuously. Doses are calculated from body weight. During cardiac arrest from ventricular fibrillation, it is pushed quickly into a vein without dilution, alongside cardiopulmonary resuscitation (CPR) and electric shocks (defibrillation). For other ventricular rhythms, it is diluted and given slowly into a vein over more than 8 minutes, because a fast injection can cause nausea, vomiting and sharp swings in blood pressure. It can be continued as a steady drip or as repeated doses every few hours, or injected into a muscle when a vein is not used, with the injection site changed each time. Because the kidneys clear bretylium from the body, doses are spaced further apart in people with reduced kidney function. When longer-term rhythm control is needed, the team usually moves to a medicine taken by mouth as soon as it is appropriate.

Side Effects

Low blood pressure is the most common effect. About half of people have some drop in blood pressure even while lying flat, and many feel dizzy, lightheaded or faint when they sit up or stand. For this reason, people receiving bretylium are usually kept lying down until the body adjusts, which can take several days. Anyone awake during treatment should tell the nurse right away about dizziness or feeling faint rather than trying to get up. Nausea and vomiting can occur, mostly when the medicine is given quickly into a vein. Soon after a dose, the initial norepinephrine release can briefly raise blood pressure or increase irregular beats. Less often, people notice chest pain or pressure, or a slow heartbeat. Rarely, bretylium has caused a dangerously high body temperature (hyperthermia), and the medicine is stopped if this is suspected.

Interactions & Warnings

Bretylium should not be used when an abnormal rhythm is thought to be caused by too much digoxin (a heart medicine also called digitalis), because its initial norepinephrine release can make digoxin toxicity worse. In people already taking digoxin, it is used only when the rhythm does not appear to come from digoxin and other medicines have not worked. It is generally avoided in people with severe aortic stenosis (a tightly narrowed heart valve) or severe pulmonary hypertension (high pressure in the lung arteries), because their hearts cannot compensate and blood pressure can fall severely. Bretylium also strengthens the blood-pressure-raising effect of medicines such as norepinephrine and dopamine, so the team uses diluted doses and watches closely when these are given together. Older antidepressants called monoamine oxidase inhibitors (MAOIs) can amplify its early norepinephrine surge. People over 65 and those with kidney disease are more likely to have problems with low blood pressure or build-up of the drug. It should be used in pregnancy only if clearly needed, and its safety and effectiveness in children have not been established.

What to Expect

Bretylium is a short-term, hospital-only treatment. Most people who receive it are critically ill, often during or just after a cardiac arrest, and may not remember getting it. Throughout treatment, the care team watches the heart rhythm on a monitor, checks blood pressure often and keeps the person lying down to limit dizziness and fainting. If the rhythm settles, the next steps focus on the cause of the arrhythmia and on longer-term protection, which may include an oral rhythm medicine or other treatments the cardiology team recommends. Evidence that any antiarrhythmic medicine improves survival during cardiac arrest is limited, and bretylium has had little modern study, so its role today is narrow.

Questions to Ask Your Doctor

  1. 1.Why was bretylium chosen for my (or my family member's) heart rhythm instead of another antiarrhythmic medicine?
  2. 2.What caused the dangerous rhythm, and what is being done to prevent it from happening again?
  3. 3.How will my kidney function or other medicines, such as digoxin, affect how this treatment is given?
  4. 4.What longer-term rhythm treatment, if any, do you recommend after the hospital stay?

Last reviewed • Oct 2026

Educational content, not medical advice.